Unique activities and high potency at disease-relevant biological targets can now be identified for ‘dark chemical matter’—compounds in high-throughput screening libraries that have been extensively tested but that have never been annotated as having biological activity.
- Anne Mai Wassermann
- Eugen Lounkine
- Meir Glick
